Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Change in Receivables: 2009-2025

Historic Change in Receivables for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to -$34.1 million.

  • BIO-TECHNE's Change in Receivables fell 3.84% to -$22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.0 million, marking a year-over-year decrease of 339.97%. This contributed to the annual value of -$34.1 million for FY2025, which is 266.23% down from last year.
  • Latest data reveals that BIO-TECHNE reported Change in Receivables of -$34.1 million as of FY2025, which was down 266.23% from $20.5 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Change in Receivables ranged from a high of $57.6 million in FY2022 and a low of -$34.1 million during FY2025.
  • For the 3-year period, BIO-TECHNE's Change in Receivables averaged around $2.4 million, with its median value being $20.5 million (2024).
  • In the last 5 years, BIO-TECHNE's Change in Receivables spiked by 337.17% in 2021 and then crashed by 266.23% in 2025.
  • BIO-TECHNE's Change in Receivables (Yearly) stood at $15.5 million in 2021, then surged by 270.42% to $57.6 million in 2022, then tumbled by 63.77% to $20.9 million in 2023, then fell by 1.60% to $20.5 million in 2024, then slumped by 266.23% to -$34.1 million in 2025.